Skip to content
Open access

Increasing cardiovascular disease risk predicts faster cognitive decline: A Bayesian analysis of a cohort of adults in rural West Texas

Aug 2026 · The journal of prevention of Alzheimer's disease · Vol 13, pp. 100651 · 1 citation · 60 references
Medicine

TL;DR

A higher 10-year ASCVD risk was associated with faster global cognitive decline and greatest risk-linked decline occurred in the attention and delayed memory domains, suggesting AHA PREVENT may aid early identification of cognitive risk.

Abstract

Highlights • A higher 10-year ASCVD risk was associated with faster global cognitive decline.• Greatest risk-linked decline occurred in the attention and delayed memory domains.• ASCVD risk via AHA PREVENT may aid early identification of cognitive risk.

Read PDF

Similar papers

Open access Sep 2026

Heterogeneity in the association between cardiovascular disease and cognitive decline: a pooled analysis of five prospective cohort studies from 24 countries

We assessed the association between cardiovascular disease (CVD) and cognitive decline in adults aged 50 years or older using pooled data from five multinational cohorts, quantified heterogeneity, and explored its potential sources.

Juan-Juan Li, Li-Li Cui, Yuan Xu et al. · 0 citations
Open access Oct 2026

Seeing the invisible: Reorienting cardiovascular risk prediction across the disease trajectory

Current risk equations miss many cardiovascular events in people classified as low risk. Prediction is simultaneously advancing on two axes: broadening predictors toward molecular omics, and expanding outcomes toward earlier subclinical atherosclerosis and later heart failure.

Xun Tang, Pei Gao · 0 citations
Open access Sep 2026

Evaluating the 8‐Year Association Between Cognition and Beta Amyloid in the Dallas Lifespan Brain Study Cohort

Mounting evidence suggests beta amyloid (Aβ) is not the sole initiating driver of cognitive decline in Alzheimer's disease (AD). This study explores whether there is an association between cognitive decline over eight years and Aβ.

J. David, Isabella Torres, Evan Smith et al. · 0 citations
Sep 2026

Cognitive safety of statin use in the elderly: Evidence from a nationally representative sample

To systematically evaluate the association between current statin use and global cognitive impairment in US older adults and examine potential variations across treatment intensity, duration, and specific cognitive domains to guide clinical cardiometabolic management.

Jia-Ying Ding, Jia-Ning Miao, Ling Zhang et al. · 0 citations
Open access Sep 2026

The Cog‐Aging: a 15‐year cohort study of cognition in Brazilian older adults

Prevalence of dementia is higher in low‐ and middle‐income countries (LMICs). However, longitudinal studies characterizing cognitive decline and its clinical and epidemiological predictors remain scarce in Brazil.

G. T. O. Engelmann, J. C. de Alvarenga, G. C. P. Moro et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.